Latest Verge Genomics News & Updates

See the latest news and media coverage for Verge Genomics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Verge Genomics

AI-powered drug discovery platform

vergegenomics.com
Headquarters
South San Francisco, United States
Founded year
2015
Company type
Private company
Number of employees
50–200

Latest news about Verge Genomics

Company announcements

  • Verge Genomics

    Verge Genomics forms strategic partnership with Devano

    The partnership leverages Verge's CONVERGE platform, integrating genomics, ML, and disease modeling for drug discovery. Full press release available at Devano.ai.

  • Verge Genomics

    Verge announces digital biomarkers detecting ALS progression

    Biomarkers measure mobility, breathing, sleep, and speech changes in VRG50635 trial's pre-treatment period using sensors and AI. Data presented at AAN meeting.

  • Verge Genomics

    Verge Genomics announces VRG201 development candidate

    VRG201 is an oral small molecule inhibiting CD38 to prevent weight regain and treat metabolic dysfunction. It is in IND-enabling studies, entering clinic in Q3 2025.

  • Verge Genomics

    Verge Genomics announces milestones in Lilly collaboration for ALS treatments

    Lilly advances two targets validated by Verge’s CONVERGE® platform, triggering milestone payments. 83% validation rate exceeds industry standards.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Verge Genomics

Track Verge Genomics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Verge Genomics competitors & trending companies

Browse news for competitors to Verge Genomics and other trending companies.